Aster Capital Management (Difc) LTD Biocryst Pharmaceuticals Inc Transaction History
Aster Capital Management (Difc) LTD
- $262 Billion
- Q4 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 149 shares of BCRX stock, worth $1,171. This represents 0.0% of its overall portfolio holdings.
Number of Shares
149
Previous 3,638
95.9%
Holding current value
$1,171
Previous $27.6 Million
95.95%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding BCRX
# of Institutions
278Shares Held
167MCall Options Held
728KPut Options Held
989K-
Vanguard Group Inc Valley Forge, PA21.9MShares$172 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$157 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$93.3 Million1.3% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$71.4 Million4.33% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY8.14MShares$64 Million1.52% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.46B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...